TipRanks
Go Ultimate55% OFF

JOEL LEWIS Insider Profile

4 Followers

JOEL LEWIS, President & CEO, Director at Galectin Therapeutics, holds 778.26K shares in Galectin Therapeutics (Ticker: GALT). Most recently, JOEL LEWIS Sold 56,332 shares of Galectin Therapeutics on Jan 13, 2026 for an estimated value of $218.57K.

JOEL LEWIS's Trading History

GALT
Galectin Therapeutics
Jan 13, 2026President & CEO, DirectorInformative Sell218.57K$2.58M
GALT
Insider Shares: 778.26K (1.21%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Jan 13, 2026Informative Sell$218.57K56,332$3.88-8.10%
Jan 06, 2026Uninformative Sell$320.55K84,000$3.81―
Jan 06, 2026Uninformative Buy$340.20K84,000$4.05―
Dec 19, 2025Uninformative Sell$55.19K7,829$7.05―
Dec 19, 2025Uninformative Buy$22.39K7,829$2.86―

You May Also Like

JOEL LEWIS insider profile FAQ

What is the percentage of profitable transactions made by JOEL LEWIS?
The percentage of profitable transactions made by JOEL LEWIS is 13%.
What is the average return per transaction made by JOEL LEWIS?
The average return per transaction made by JOEL LEWIS is -32.30%.
What stocks does JOEL LEWIS hold?
JOEL LEWIS holds: GALT stocks.
What was JOEL LEWIS’s latest transaction?
JOEL LEWIS’s latest transaction was an Informative Sell of $218.57K.
What was JOEL LEWIS's most profitable transaction?
JOEL LEWIS’s most profitable transaction was an Informative Buy of GALT stock on February 21, 2023. The return on the trade was 16.20%.
What is JOEL LEWIS's role in Galectin Therapeutics?
JOEL LEWIS's role in Galectin Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.